news
« BACK
Chemistry - Health - 27.03.2023 
Accurate rapid tests made from smart graphene paper
A team led by ETH Zurich chemical engineers Chih-Jen Shih and Andrew deMello have developed a rapid test system made of smart graphene paper. It only costs a few Swiss Rappen per test strip, is easy to use but is as accurate as lab measurements. The approach will impact more than just disease monitoring.
Health - Innovation - 23.03.2023 
More efficient instruments for cataract surgery
One and a half million times a year, the instruments of eye surgery specialist Oertli Instrumente AG are used for cataract operations. In cooperation with the Lucerne University of Applied Sciences, the Rhine Valley company is working on instruments that will make the operation safer and even more efficient.
Health - Innovation - 22.03.2023 
Shining a light into the ’’black box’’ of AI
An international team led by the University of Geneva, HUG and NUS has developed an innovative method for evaluating AI interpretability methods, with the aim of deciphering the basis of AI reasoning and possible biases. Researchers from the University of Geneva , the Geneva University Hospitals (HUG), and the National University of Singapore (NUS) have developed a novel method for evaluating the interpretability of artificial intelligence (AI) technologies, opening the door to greater transparency and trust in AI-driven diagnostic and predictive tools.
Health - 17.03.2023 
How tumours transform blood vessels
Increasingly dense cell clusters in growing tumours convert blood vessels into fibre-filled channels. This makes immune cells less effective, as findings by researchers from ETH Zurich and the University of Strasbourg suggest. It was almost ten years ago that researchers first observed that tumours occurring in different cancers - including colorectal cancer, breast cancer and melanoma - exhibit channels leading from the surface to the inside of the cell cluster.
Health - Pharmacology - 15.03.2023 
Bypassing antibiotic resistance with a combination of drugs
By combining an antibiotic with an anti-cancer agent, an international team has developed a treatment capable of circumventing the antibiotic resistance of the bacterium Enterococcus faecalis. Antibiotic resistance is one of the world's most pressing health challenges: in 2019, nearly 5 million people died from an infection associated with or attributed to antibiotic resistance.
Health - Innovation - 15.03.2023 
Smart ring offers a simple way to monitor your health
Senbiosys, an EPFL spin-off, has unveiled a jewelry-like smart ring that incorporates all the health-monitoring features currently available in smart watches. The company's notable achievement in miniaturization - made possible thanks to the world's smallest sensor, developed at EPFL - appears to have major market potential, as its recent crowdfunding campaign raised five times more capital than expected.
Life Sciences - Health - 14.03.2023 
The legacy of trauma
Emotional trauma can have far-reaching ripple effects and may even reverberate across generations. Professors Isabelle Mansuy and Katharina Gapp study how the effects of trauma can be inherited through epigenetic mechanisms. Our parents and grandparents form part of who we are. They reared us and served as our role models, and they also passed on their genes.
Health - 06.03.2023 
The marathon runners of the immune system
When it comes to chronic infections and cancer, a particular type of immune cell plays a central role in our defenses. Researchers at the University of Basel have uncovered the key to the tenacity of these immune cells in coping with the marathon that is fighting a chronic infection. Their results lay the foundations for more effective therapies and vaccination strategies.
Life Sciences - Health - 01.03.2023 
How to generate new neurons in the brain
A team of biologists led by UNIGE and UNIL has discovered how to awaken neural stem cells and reactivate them in adult mice. Some areas of the adult brain contain quiescent, or dormant, neural stem cells that can potentially be reactivated to form new neurons. However, the transition from quiescence to proliferation is still poorly understood.
Health - Pharmacology - 21.02.2023
Health - Life Sciences - 21.02.2023
Pharmacology - Health - 20.02.2023 
Using light to switch drugs on and off
Scientists at the Paul Scherrer Institute PSI have used the Swiss X-ray free-electron laser SwissFEL and the Swiss Light Source SLS to make a film that could give a decisive boost to developing a new type of drug. They made the advance in the field of so-called photopharmacology, a discipline that develops active substances which can be specifically activated or deactivated with the help of light.
Health - Life Sciences - 20.02.2023 
Oral bacteria may increase heart disease risk
Researchers at EPFL have found that infection with a common bacterium that is linked to periodontal disease, oral cancers, and bad breath may cause a small increase in the risk of cardiovascular disease. A combination of genetic and environmental risk factors contributes to heart disease, which is responsible for about a third of all deaths worldwide.
Health - Life Sciences - 07.02.2023 
How age and sex influence our body clocks
Researchers have uncovered the intricacies of gene expression rhythms in humans, shedding new light on how sex and age influence our body clocks. The human body runs on a finely tuned clock synchronized to the 24-hour cycle of Earth's rotation, known as the circadian clock, which controls various physiological processes such as the sleep-wake cycle, hormone production, and metabolism.
Health - Psychology - 06.02.2023 
Mental Health Distress Increased for Zambian Mothers During the COVID-19 Pandemic
A study by Swiss TPH and partners found that the COVID-19 pandemic has led to an increase in mental health concerns among mothers in Zambia. The study highlights the need for public health interventions for vulnerable groups in low-resource settings. The findings were recently published in the peer-reviewed journal PLOS One.
Health - 06.02.2023 
Can Netflix keep you from sleeping soundly?
Watching suspenseful TV series with cliffhangers before going to sleep has only minor effects on sleep. That's what scientists at the University of Freiburg have shown. The study reveals what happens in our brains when we sleep after a binge-watching session . Does binge-watching suspenseful TV series before going to sleep have a real impact on our sleep? This is the question that Professors Björn Rasch and Andreas Fahr from the University of Fribourg asked themselves in a project entitled 'Excessive Media Use in Times of Netflix', funded by the Swiss National Science Foundation (SNSF).
Health - Pharmacology - 06.02.2023
Health - 02.02.2023 
Avoiding burnout of white blood cells
A research group at the University of Basel has identified a gene that drives T lymphocytes to exhaustion. This finding opens up new approaches for more effective immunotherapies. A tough battle requires endurance. This is also true for white blood cells as they tackle cancer - or more specifically for T lymphocytes or T cells, a group of white blood cells involved in the immune system's fight against cancer cells.
Health - 02.02.2023 
A microfluidic device for detecting SARS-CoV-2
A new microfluidic device developed by scientists in Switzerland can detect the SARS-CoV-2 virus with high accuracy and speed, using a unique DNA/RNA duplex technology. The device can prove to be a game-changer in the fight against the ongoing COVID-19 pandemic. The ongoing COVID-19 pandemic created an urgent need for ways to detect the SARS-CoV-2 virus quickly, accurately and on a massive scale in order to control its spread.
Health - 02.02.2023 
A microfluidic for detecting SARS-CoV-2
A new microfluidic device developed by scientists in Switzerland can detect the SARS-CoV-2 virus with high accuracy and speed, using a unique DNA/RNA duplex technology. The device can prove to be a game-changer in the fight against the ongoing COVID-19 pandemic. The ongoing COVID-19 pandemic created an urgent need for ways to detect the SARS-CoV-2 virus quickly, accurately and on a massive scale in order to control its spread.
Health
Results 1 - 20 of 1228.
A team led by ETH Zurich chemical engineers Chih-Jen Shih and Andrew deMello have developed a rapid test system made of smart graphene paper. It only costs a few Swiss Rappen per test strip, is easy to use but is as accurate as lab measurements. The approach will impact more than just disease monitoring.
One and a half million times a year, the instruments of eye surgery specialist Oertli Instrumente AG are used for cataract operations. In cooperation with the Lucerne University of Applied Sciences, the Rhine Valley company is working on instruments that will make the operation safer and even more efficient.
An international team led by the University of Geneva, HUG and NUS has developed an innovative method for evaluating AI interpretability methods, with the aim of deciphering the basis of AI reasoning and possible biases. Researchers from the University of Geneva , the Geneva University Hospitals (HUG), and the National University of Singapore (NUS) have developed a novel method for evaluating the interpretability of artificial intelligence (AI) technologies, opening the door to greater transparency and trust in AI-driven diagnostic and predictive tools.
Increasingly dense cell clusters in growing tumours convert blood vessels into fibre-filled channels. This makes immune cells less effective, as findings by researchers from ETH Zurich and the University of Strasbourg suggest. It was almost ten years ago that researchers first observed that tumours occurring in different cancers - including colorectal cancer, breast cancer and melanoma - exhibit channels leading from the surface to the inside of the cell cluster.
By combining an antibiotic with an anti-cancer agent, an international team has developed a treatment capable of circumventing the antibiotic resistance of the bacterium Enterococcus faecalis. Antibiotic resistance is one of the world's most pressing health challenges: in 2019, nearly 5 million people died from an infection associated with or attributed to antibiotic resistance.
Senbiosys, an EPFL spin-off, has unveiled a jewelry-like smart ring that incorporates all the health-monitoring features currently available in smart watches. The company's notable achievement in miniaturization - made possible thanks to the world's smallest sensor, developed at EPFL - appears to have major market potential, as its recent crowdfunding campaign raised five times more capital than expected.
Emotional trauma can have far-reaching ripple effects and may even reverberate across generations. Professors Isabelle Mansuy and Katharina Gapp study how the effects of trauma can be inherited through epigenetic mechanisms. Our parents and grandparents form part of who we are. They reared us and served as our role models, and they also passed on their genes.
When it comes to chronic infections and cancer, a particular type of immune cell plays a central role in our defenses. Researchers at the University of Basel have uncovered the key to the tenacity of these immune cells in coping with the marathon that is fighting a chronic infection. Their results lay the foundations for more effective therapies and vaccination strategies.
A team of biologists led by UNIGE and UNIL has discovered how to awaken neural stem cells and reactivate them in adult mice. Some areas of the adult brain contain quiescent, or dormant, neural stem cells that can potentially be reactivated to form new neurons. However, the transition from quiescence to proliferation is still poorly understood.
When is remdesivir effective for COVID-19?
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific group of patients benefits the most from the drug. Since the outbreak of the COVID-19 pandemic, researchers and medical practitioners have made a massive effort to find effective treatments for the illness.
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific group of patients benefits the most from the drug. Since the outbreak of the COVID-19 pandemic, researchers and medical practitioners have made a massive effort to find effective treatments for the illness.
Modeling liver and kidney disease
In two separate studies, researchers at EPFL have carried out extensive tests to develop the best mouse models for studying kidney and liver diseases. The findings provide crucial insights into both conditions, and are expected to open up new avenues of research and treatment. "In these two studies we investigated how the mouse's genetic background affects the susceptibility to fatty liver disease and the transition from acute kidney injury to chronic kidney disease," says Professor Johan Auwerx at EPFL.
In two separate studies, researchers at EPFL have carried out extensive tests to develop the best mouse models for studying kidney and liver diseases. The findings provide crucial insights into both conditions, and are expected to open up new avenues of research and treatment. "In these two studies we investigated how the mouse's genetic background affects the susceptibility to fatty liver disease and the transition from acute kidney injury to chronic kidney disease," says Professor Johan Auwerx at EPFL.
Scientists at the Paul Scherrer Institute PSI have used the Swiss X-ray free-electron laser SwissFEL and the Swiss Light Source SLS to make a film that could give a decisive boost to developing a new type of drug. They made the advance in the field of so-called photopharmacology, a discipline that develops active substances which can be specifically activated or deactivated with the help of light.
Researchers at EPFL have found that infection with a common bacterium that is linked to periodontal disease, oral cancers, and bad breath may cause a small increase in the risk of cardiovascular disease. A combination of genetic and environmental risk factors contributes to heart disease, which is responsible for about a third of all deaths worldwide.
Researchers have uncovered the intricacies of gene expression rhythms in humans, shedding new light on how sex and age influence our body clocks. The human body runs on a finely tuned clock synchronized to the 24-hour cycle of Earth's rotation, known as the circadian clock, which controls various physiological processes such as the sleep-wake cycle, hormone production, and metabolism.
A study by Swiss TPH and partners found that the COVID-19 pandemic has led to an increase in mental health concerns among mothers in Zambia. The study highlights the need for public health interventions for vulnerable groups in low-resource settings. The findings were recently published in the peer-reviewed journal PLOS One.
Watching suspenseful TV series with cliffhangers before going to sleep has only minor effects on sleep. That's what scientists at the University of Freiburg have shown. The study reveals what happens in our brains when we sleep after a binge-watching session . Does binge-watching suspenseful TV series before going to sleep have a real impact on our sleep? This is the question that Professors Björn Rasch and Andreas Fahr from the University of Fribourg asked themselves in a project entitled 'Excessive Media Use in Times of Netflix', funded by the Swiss National Science Foundation (SNSF).
New biomarker for disease progression in multiple sclerosis
The autoimmune disease multiple sclerosis can take a variety of courses. Determining the current and future course of the disease is important in order to slow down its course as much as possible. Researchers at the University of Basel have presented a biomarker whose values in the blood allow such predictions.
The autoimmune disease multiple sclerosis can take a variety of courses. Determining the current and future course of the disease is important in order to slow down its course as much as possible. Researchers at the University of Basel have presented a biomarker whose values in the blood allow such predictions.
A research group at the University of Basel has identified a gene that drives T lymphocytes to exhaustion. This finding opens up new approaches for more effective immunotherapies. A tough battle requires endurance. This is also true for white blood cells as they tackle cancer - or more specifically for T lymphocytes or T cells, a group of white blood cells involved in the immune system's fight against cancer cells.
A new microfluidic device developed by scientists in Switzerland can detect the SARS-CoV-2 virus with high accuracy and speed, using a unique DNA/RNA duplex technology. The device can prove to be a game-changer in the fight against the ongoing COVID-19 pandemic. The ongoing COVID-19 pandemic created an urgent need for ways to detect the SARS-CoV-2 virus quickly, accurately and on a massive scale in order to control its spread.
A new microfluidic device developed by scientists in Switzerland can detect the SARS-CoV-2 virus with high accuracy and speed, using a unique DNA/RNA duplex technology. The device can prove to be a game-changer in the fight against the ongoing COVID-19 pandemic. The ongoing COVID-19 pandemic created an urgent need for ways to detect the SARS-CoV-2 virus quickly, accurately and on a massive scale in order to control its spread.
